Astec LifeSciences Limited (BOM:533138)
India · Delayed Price · Currency is INR | Market Cap | 15.59B -17.9% |
| Revenue (ttm) | 4.41B +9.3% |
| Net Income | -665.97M |
| EPS | -30.16 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 5,296 |
| Open | 714.05 |
| Previous Close | 711.85 |
| Day's Range | 693.00 - 716.80 |
| 52-Week Range | 512.35 - 936.00 |
| Beta | n/a |
| Analysts | Hold |
| Price Target | 670.00 (-4.05%) |
| Earnings Date | Oct 30, 2026 |
About Astec LifeSciences
Astec LifeSciences Limited, together with its subsidiaries, manufactures and sells agrochemical active ingredients and pharmaceutical intermediates in India. The company provides triazole fungicides for use in field crops; foliar treatment for the control of scab, powdery mildew, shot-hole, blossom blight, and rust; seed treatment for the control of seed and soil-borne diseases in cotton and maize, as well as grains, such as barley, rice, and wheat; post-harvest drench; and food additive and wood preservatives. It also provides herbicides, inse... [Read more]
Financial Performance
In fiscal year 2026, Astec LifeSciences's revenue was 4.48 billion, an increase of 17.53% compared to the previous year's 3.81 billion. Losses were -809.18 million, -39.95% less than in 2025.
Financial StatementsAnalyst Summary
According to 2 analysts, the average rating for 533138 stock is "Hold." The 12-month stock price target is ₹670.00, which is a decrease of -4.05% from the latest price.
News
Astec LifeSciences announces 32nd AGM and book closure dates
Astec LifeSciences Limited has released its Annual Report for the financial year 2025-26 and announced the schedule for its 32nd Annual General Meeting (AGM). The AGM is set to take…
Astec LifeSciences announces 32nd AGM and closure of share transfer books
Astec LifeSciences has released its Annual Report for the financial year 2025-26, detailing plans for its 32nd Annual General Meeting (AGM). The AGM is scheduled for 31st July 2026 at…
Astec LifeSciences appoints new directors and approves related party transactions
Astec LifeSciences Limited has announced the successful passing of several resolutions via a postal ballot, as detailed in a regulatory filing. The resolutions, which were passed with the requisite ma...
Astec LifeSciences approves key appointments and related party transactions
Astec LifeSciences Limited has announced the results of its recent postal ballot, confirming the approval of several significant resolutions. The resolutions, which were passed with the requisite majo...
Astec LifeSciences approves key director appointments and related party transactions
Astec LifeSciences Limited has announced the results of its postal ballot, confirming the approval of several significant resolutions. The resolutions, passed with the requisite majority, include the ...
Astec LifeSciences announces resignation of General Manager Vijayalakshmi Iyer
Astec LifeSciences Limited has announced the resignation of Ms. Vijayalakshmi Iyer, who served as the General Manager of Human Resources. The resignation was tendered and accepted on 5th June 2026,…
Astec LifeSciences' General Manager of HR resigns to pursue new opportunity
Astec LifeSciences Limited has announced the resignation of Ms. Vijayalakshmi Iyer from her position as General Manager of Human Resources. The resignation, effective from 5th June 2026, was accepted ...
Astec LifeSciences appoints Vishal Sharma as non-executive director
Astec LifeSciences Limited has announced the appointment of Mr. Vishal Sharma as a Director (Non-Executive, Non-Independent), liable to retire by rotation. This decision was approved by the company's ...
Astec LifeSciences files annual secretarial compliance report for FY 2026
Astec LifeSciences Limited has filed its Annual Secretarial Compliance Report with the National Stock Exchange of India Limited (NSE) and BSE Limited in accordance with Regulation 24A(2) of the Securi...
Astec LifeSciences notifies shareholders of equity share transfer to IEPF
Astec LifeSciences Limited has issued an important notice to its shareholders regarding the transfer of equity shares to the Investor Education and Protection Fund (IEPF). This action pertains to shar...
Astec LifeSciences alerts shareholders on potential transfer of unclaimed dividends to IEPF
Astec LifeSciences Limited has issued an important notice to its shareholders regarding the potential transfer of equity shares to the Investor Education and Protection Fund (IEPF) due to unclaimed di...
Astec Lifesciences share price swings 22% today — Details
Astec Lifesciences shares witnessed sharp volatility in Monday’s trading session, with the stock swinging nearly 22% between its intraday high and low amid heavy investor activity. The stock opened at...
Astec LifeSciences grants 1,142 stock options under ESOP 2012
Astec LifeSciences Limited has announced the grant of 1,142 stock options to an eligible grantee under its Employees Stock Option Plan, 2012 (ESOP 2012). The move was approved by the…
Astec LifeSciences approves audited financial results for FY26
Astec LifeSciences has announced the approval of its audited financial results for the quarter and financial year ended 31st March 2026. The decision was made during a Board meeting held…
Astec LifeSciences reports ₹161.3 crore income in Q4 FY26, a 34% increase
Astec LifeSciences Limited has announced its consolidated financial results for the fourth quarter and year ended 31st March 2026, showcasing significant growth in revenue and a reduction in losses. I...
Astec LifeSciences reports 34% revenue growth in Q4 FY26 with ₹161.3 crore income
Astec LifeSciences Limited has announced its financial results for the fourth quarter and the financial year ending 31st March 2026, showcasing a robust performance. The company reported a consolidate...
Nadir Godrej to step down as chairperson of Godrej Industries, Godrej Agrovet and Astec LifeSciences; new leadership announced
Nadir Godrej will step down as chairperson across three listed Godrej Group companies — Godrej Industries, Godrej Agrovet and Astec LifeSciences — as he approaches the age of 75 in…
Astec LifeSciences appoints Vishal Sharma as chairperson following Nadir Godrej's retirement
Astec LifeSciences has announced significant changes in its board of directors, including the retirement of Mr. Nadir Godrej as Chairperson and Director, effective 13th April, 2026. Mr. Godrej's depar...
Astec LifeSciences confirms Rs 4.36 crore interest payment on debentures
Astec LifeSciences has confirmed the timely payment of interest on its non-convertible debentures, amounting to ₹4,36,10,000. The payment was made on the due date of 27th March 2026, as per…
Astec Lifesciences shares rally sharply over 18% today: Details here
Astec Lifesciences shares witnessed a sharp rally on Wednesday, surging over 18% intraday and drawing strong investor attention on Dalal Street. The stock touched a high of ₹620.95 during the…
Astec LifeSciences sells asset to Clean Max Enviro for Rs 26,000
Astec LifeSciences has completed the sale of an asset to Clean Max Enviro Energy Solutions, receiving a consideration of ₹26,000 for the transaction. The agreement for sale was entered into…
Astec Lifesciences shares rally over 7% today; Details here
Astec Lifesciences witnessed a sharp upward move in today’s session, with the stock rising more than 7% amid strong trading...
Astec Lifesciences shares jump over 7% today; Details here
Astec Lifesciences saw a strong upswing in early Friday trade, with the stock rallying more than 7%. The share opened...
Astec LifeSciences shares rise over 4% after Burjis Godrej appointed as Managing Director
Shares of Astec LifeSciences surged 4.58% to Rs 706.15 in Monday’s session after the company appointed Burjis Godrej as Managing Director for a five-year term starting April 1, 2025. Burjis, the elder...